TABLE 1.

The distribution of HLA-B* frequencies in HIV- infected patients and controls

Genotype	HIV (2n=832)	Control (2n=832)	Statistical analysis	p
HLA-B*	n-AF (%)	n-AF (%)	OR-(95% CI)
07	18 (2.16)	48 (5.77)	0.36 (0.21–0.63)	0.0003
08	34 (4.09)	19 (2.28)	1.82 (1.03–3.22)	0.051
12	0 (0.00)	3 (0.36)	–	–
13	21 (2.52)	32 (3.85)	0.65 (0.37–1.13)	0.163
14	12 (1.44)	47 (5.65)	0.24 (0.13–0.46)	<0.0001
15	45 (5.41)	28 (3.37)	1.64 (1.01–2.66)	0.042
18	54 (6.49)	68 (8.17)	0.78 (0.54–1.13)	0.188
19	3 (0.36)	2(0.24)	1.50 (0.25–9.01)	0.687
27	9 (1.08)	18 (2.16)	0.49 (0.22–1.11)	0.121
35	147 (17.67)	74 (8.89)	2.20 (1.63–2.96)	<0.0001
37	13 (1.56)	5 (0.60)	2.63 (0.93–7.40)	0.097
38	32 (3.85)	42 (5.05)	0.75 (0.47–1.20)	0.234
39	13 (1.56)	4 (0.48)	3.29 (1.07–10.12)	0.051
40	23 (2.76)	32 (3.85)	0.71 (0.41–1.23)	0.273
41	14 (1.68)	16 (1.92)	0.87 (0.42–1.80)	0.854
42	1 (0.12)	0 (0.00)	–	–
44	64 (7.69)	67 (8.05)	0.95 (0.67–1.36)	0.785
45	4 (0.48)	0 (0.00)	–	–
46	3 (0.36)	5 (0.60)	0.60 (0.14–2.51)	0.726
47	2 (0.24)	4 (0.48)	0.50 (0.10–2.73)	0.452
48	9 (1.08)	3 (0.36)	3.02 (0.82–11.20)	0.147
49	44 (5.29)	30 (3.61)	1.49 (0.93–2.40)	0.096
50	41 (4.93)	34 (4.09)	1.22 (0.76–1.94)	0.408
51	128 (15.38)	72 (8.65)	1.92 (1.41–2.61)	<0.0001
52	36 (4.33)	36 (4.33)	1.00 (0.62–1.60)	1.000
53	3 (0.36)	6 (0.72)	0.50 (0.12–2.00)	0.507
54	0 (0.00)	5 (0.60)	–	–
55	15 (1.80)	84 (10.10)	0.16 (0.09–0.29)	<0.0001
56	5 (0.60)	0 (0.00)	–	–
57	10 (1.20)	17 (2.04)	0.58 (0.27–1.28)	0.244
58	29 (3.49)	28 (3.73)	0.93 (0.56–1.56)	0.793

HLA: Human leukocyte antigen; HIV: Human immunodeficiency virus; AF: Allele frequency; OR: Odds ratio; CI: Confidence interval; 2n: Each individual was represented by two codominant allelic data.